Q2 2026 adjusted loss per share
Company: CoreWeave
The claim, verbatim
Adjusted loss per share in Q2 was $1.03, below the $1.20 per share target
Source (primary)
‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - Stocktwits (-, news_article)
View cached copy (2026-08-31)Live source ↗Archive.org ↗
Quote: “Adjusted loss per share of $1.03 was below the $1.20 per share target.”
How we checked this
Checked on October 10, 2026. The cited source supports every part of this claim.
The article states the $1.03 adjusted loss per share and that it was below the $1.20 per share target.
Confirmed in the source:
- CoreWeave's Q2 adjusted loss per share was $1.03
- The $1.03 adjusted loss per share was below the $1.20 per share target
What we did: Read our cached copy of the publisher (https://stocktwits.com/news-articles/markets/equity/pharma-bro-martin-shkreli-covered-core-weave-short-position-crwv-stock-slides-for-third-session/cZYBm3QRJNI) in full (4,931 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms ‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - Stocktwits
Quote: “Adjusted loss per share of $1.03 was below the $1.20 per share target.”
confirms ‘Pharma Bro’ Martin Shkreli ‘Covered’ CoreWeave Short Position: CRWV Stock Slides For Third Session - TradingView
Quote: “Adjusted loss per share of $1.03 was below the $1.20 per share target.”